Causal Relationship Between Antibody‐Mediated Immune Responses of Chlamydia trachomatis Infection and Reproductive Tract Complications: A Bidirectional Mendelian Randomization Study
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70036 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Yanggang Hong und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Chlamydia trachomatis, Chlamydia Infections, Mendelian Randomization Analysis, Genome-Wide Association Study. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National College Students Innovation and Entrepreneurship Training Program, China, Zhejiang University Student Science and Technology Innovation Activity Plan, China.
Abstract (Originalsprache)
Purpose
Characterized as a prevalent sexually transmitted infection, Chlamydia trachomatis is intimately associated with reproductive tract complications, including pelvic inflammatory disease (PID) and infertility. However, the causal relationships between C. trachomatis infection and reproductive tract complications remain elusive.
Methods
To investigate the causal relationships between C. trachomatis antibodies and seven reproductive tract complications, we conducted a bidirectional Mendelian randomization (MR) analysis. The fundamental data were originated from the genome‐wide association studies (GWAS) database. While the influences of C. trachomatis antibodies on reproductive tract complications such as tubal factor infertility (TFI) and PID have been assessed, the reverse MR analysis examined how these complications impacted C. trachomatis antibodies.
Results
The forward MR analysis revealed that the upregulation of MOMP A antibodies was significantly associated with a reduced risk of TFI (OR = 0.932, p = 0.007), while MOMP D antibodies were associated with a reduced risk of ectopic pregnancy (EP) (OR = 0.923, p = 0.005). However, no significant causal interactions were identified for other reproductive complications. Moreover, the reverse MR analysis indicated that cervicitis was significantly correlated with lower MOMP A antibody levels (OR = 0.900, p = 0.016).
Conclusions
This study demonstrates the protective effects of C. trachomatis antibodies, particularly MOMP A and MOMP D, against TFI and EP, respectively. It also emphasizes the potential role of cervical inflammation in shaping immune responses to C. trachomatis . These insights provide a foundation for future research to develop immune‐targeted therapies and integrated approaches for preventing and managing C. trachomatis ‐related reproductive tract complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- The First School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
ORCID-Profile: Yanggang Hong
Förderung
- National College Students Innovation and Entrepreneurship Training Program, China
- Zhejiang University Student Science and Technology Innovation Activity Plan, China
Zitieren
APA
Hong, Y., & Wang, Y. (2025). Causal Relationship Between Antibody‐Mediated Immune Responses of Chlamydia trachomatis Infection and Reproductive Tract Complications: A Bidirectional Mendelian Randomization Study. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70036
Vancouver
Hong Y, Wang Y. Causal Relationship Between Antibody‐Mediated Immune Responses of Chlamydia trachomatis Infection and Reproductive Tract Complications: A Bidirectional Mendelian Randomization Study. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70036
BibTeX
@article{Hong2025,
author = {Hong, Yanggang and Wang, Yi},
title = {Causal Relationship Between Antibody‐Mediated Immune Responses of Chlamydia trachomatis Infection and Reproductive Tract Complications: A Bidirectional Mendelian Randomization Study},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70036}
}
EUVIMED